Thema: US4169062043
HBIO, US4169062043
stock-1863880_1920.jpg - Foto: THN
Harvard Bioscience stock faces Q3 test as margin concerns persist
Harvard Bioscience stock enters its Q3 test after a revenue rebound and higher guidance. Investors are watching margins and cash conversion.
ad-hoc-news.de, vor 53 Minuten
HBIO, US4169062043
Harvard Bioscience forms advisory board. Holder reports ...
Harvard Bioscience announced five board members on October 6, 2026. Q2 revenue of USD 22.73 million frames Harvard Bioscience stock.
ad-hoc-news.de, 16.10.26 00:37 Uhr
HBIO, US4169062043
Harvard Bioscience grows revenue 11.10 percent: what it ...
